Finance

Beta
Lists
000513:SHE
Livzon Pharmaceutical Group Inc
CN¥30.66
+1.02%
(+0.31) 1D
Jun 5, 3:05:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000513...
Open
CN¥30.36
High
CN¥30.97
Low
CN¥30.32
Mkt. cap
24.84B
Avg. vol.
4.94M
Volume
3.73M
P/E ratio
13.92
52-wk high
CN¥44.87
52-wk low
CN¥29.95
EPS
CN¥2.20
Shares outstanding
588.10M
No. of employees
9K
Open
CN¥30.36
High
CN¥30.97
Low
CN¥30.32
Mkt. cap
24.84B
Avg. vol.
4.94M
Volume
3.73M
P/E ratio
13.92
52-wk high
CN¥44.87
52-wk low
CN¥29.95
EPS
CN¥2.20
Shares outstanding
588.10M
No. of employees
9K
News stories
From sources across the web
About Livzon Pharmaceutical Group Inc
CEO-
Employees8.88K
FoundedJan 26, 1985
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.09B
2.84B
2.90B
2.87B
Cost of goods sold
1.03B
922.95M
1.07B
979.89M
Cost of revenue
1.03B
922.95M
1.07B
979.89M
Research and development expenses
215.97M
251.21M
254.68M
169.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.08B
1.02B
1.13B
868.91M
Operating expense
1.33B
1.22B
1.50B
1.06B
Total operating expenses
2.36B
2.15B
2.57B
2.04B
Operating income
731.39M
697.89M
337.97M
835.51M
Other non operating income
-3.92M
-5.26M
3.78M
-23.80M
EBT including unusual items
869.52M
668.44M
365.51M
851.71M
EBT excluding unusual items
855.60M
744.09M
362.05M
871.56M
Income tax expense
121.94M
89.40M
84.72M
127.70M
Effective tax rate
14.02%
13.37%
23.18%
14.99%
Other operating expenses
35.90M
-47.89M
121.57M
18.39M
Net income
644.38M
473.01M
269.15M
576.91M
Net profit margin
20.84%
16.63%
9.27%
20.09%
Earnings per share
-
-
-
-
Interest and investment income
121.01M
87.39M
56.74M
69.53M
Interest expense
-15.01M
-13.79M
-13.51M
-9.68M
Net interest expenses
106.00M
73.59M
43.23M
59.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
867.79M
835.21M
474.48M
972.03M
Gain or loss from assets sale
149.72K
-149.72K
3.21M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more